Aug 14, 2026·Score 86·Type A — Value-style analysisUsed for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety.Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology →$49.78
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses.$47.00($45.00–$49.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology →$55.00
Expected Return
Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Type A - Enact Holdings, Inc. (ACT) 20260814 Stock Analysis
📅 Enact Key Upcoming Events
August 20, 2026Ex-Dividend Date (Confirmed)
Description: Shareholders of record on this date will receive the declared quarterly dividend payout of $0.24 per share, payable on September 17, 2026, reflecting the company’s sustained commitment to returning excess capital.
November 04, 2026Q3 2026 Earnings Release (Estimated)
Description: The market will closely monitor persistency rates, new insurance written (NIW) volumes, and any further adjustments to the reserve release expectations amidst housing affordability headwinds and the ongoing phase-in of updated PMIERs capital standards.
February 03, 2027Q4 2026 Earnings Release (Estimated)
Description: Investors will focus on the full-year capital return totals, the depletion rate of the current $500 million share repurchase authorization, and the final impact of the phased transition to the Federal Housing Finance Agency’s updated regulatory capital guidelines.
🏢 Step 1: Enact Company Overview & Business Model
Q1-A1. What is Enact?
Company Name (Ticker): Enact Holdings, Inc. (ACT)
Sector: Financials
Exchange: NASDAQ
Founded: 1981
Listing Date: September 15, 2021
Fiscal Year End: December
Headquarters: United States, Raleigh
CEO: Rohit Gupta
Market Cap: $6.84B
Shares Outstanding: 137.48M
Current Stock Price:$49.78
Annual Dividend Yield:1.93%
Ex-dividend Date: August 20, 2026 (ET)
As-of: August 14, 2026 (ET)
Q1-A2. How Does Enact Make Money?
Business Model: Enact operates as a premier private mortgage insurance (PMI) provider within the United States housing finance ecosystem. The company generates revenue by selling credit protection to mortgage lenders and ultimate investors, covering a specified portion of the unpaid principal balance on conventional residential mortgage loans. This coverage is typically mandated for borrowers who provide down payments of less than 20%, resulting in loan-to-value (LTV) ratios exceeding 80%.
Value Proposition to Lenders and GSEs: By assuming the first-loss credit risk on high-LTV mortgages, Enact facilitates the seamless sale of these mortgages into the secondary market to government-sponsored enterprises (GSEs), primarily the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac). The GSEs require this insurance to protect taxpayers from default risks. Enact’s underwriting effectively acts as a critical enabler of liquidity in the housing market, empowering borrowers to achieve homeownership sooner while completely shielding lenders and the GSEs from localized borrower defaults.
Underwriting and Risk Selection: The company leverages a highly sophisticated, proprietary risk analytics model known as the One Analytical Framework, which integrates multi-dimensional attribute-based modeling to dynamically price risk based on granular loan-level data, including FICO scores, debt-to-income (DTI) ratios, and geographic housing market trends.
Q1-A3. Enact’s Revenue Segments & Core Income Sources
Net Premiums Earned: The absolute core of Enact’s revenue generation is derived from the premiums paid by borrowers on active mortgage insurance policies, constituting roughly 80% of total revenue. As of the trailing twelve months leading into mid-2026, total revenues stood at approximately $1.24 billion. The premium structure is overwhelmingly weighted toward monthly premium policies, which represented 96% of New Insurance Written (NIW) in late 2025 and 2026. This monthly structure creates an incredibly stable, recurring revenue stream known as the “Insurance In-Force” (IIF) book, which currently totals a record $274 billion. The company also writes a small fraction of single-premium policies.
Net Investment Income: The secondary revenue engine is Enact’s highly rated, $6.2 billion fixed-income investment portfolio. Because the company collects premiums upfront but pays claims years later (if at all), it amasses a massive float. This float is invested conservatively. Due to the structurally elevated interest rate environment persisting through 2025 and 2026, net investment income has surged, contributing significantly to pre-tax profit margins. For instance, in Q2 2026, net investment income reached $73 million, up from $66 million in the prior year.
Q1-A4. Who Are Enact’s Competitors?
Direct Competitors: Enact operates within a highly consolidated, impenetrable oligopoly consisting of only six active private mortgage insurers in the United States. The company directly competes for lender allocations against MGIC Investment Corporation (MTG), Radian Group Inc. (RDN), Essent Group Ltd. (ESNT), NMI Holdings, Inc. (NMIH), and Arch Mortgage Insurance (ACGL).
Substitutes and Government Alternatives: The primary substitute threat originates from government-backed mortgage insurance programs, specifically the Federal Housing Administration (FHA) and the Department of Veterans Affairs (VA). The FHA represents the largest structural competitor, targeting a similar demographic of first-time, low-down-payment homebuyers. The division of market share between private MI and the FHA fluctuates based on legislative adjustments to FHA pricing and GSE guarantee fees.
Industry Position: Despite fierce competition, Enact holds a formidable market share, accounting for approximately 16.6% to 17.1% of the industry’s new insurance written (NIW). The company distinguishes itself not through aggressive price-cutting—which is effectively neutralized by transparent, risk-based pricing matrices shared across the industry—but through deep technological integrations into the loan origination systems (LOS) of over 1,600 lenders, superior claims-paying reliability, and comprehensive customer service workflows.
Q1-A5. Enact Key Events: Past 12 Months
October 30, 2025Secured $170 Million Forward Excess of Loss (XOL) Reinsurance
Description: Executing on its relentless credit risk transfer (CRT) strategy, Enact’s flagship entity, Enact Mortgage Insurance Corporation, secured approximately $170 million of forward XOL reinsurance coverage for the 2027 book year from a panel of highly rated reinsurers. This proactive maneuver effectively caps future loss severity and reduces the required capital the company must hold under regulatory frameworks, freeing up liquidity for aggressive shareholder returns.
February 03, 2026Announced $500 Million Share Repurchase Program
Description: Coinciding with its Q4 2025 earnings release, Enact’s Board of Directors authorized an immense new $500 million share repurchase program, replacing previous authorizations. Given the company’s sub-$7 billion market capitalization, this authorization represents a potential retirement of roughly 7% of the entire outstanding float, signaling profound executive confidence in the durability of the company’s PMIERs capital sufficiency.
April 21, 2026Fitch Affirms ‘A’ Insurer Financial Strength Rating
Description: Fitch Ratings officially affirmed the ‘A’ Insurer Financial Strength (IFS) rating of Enact’s lead operating subsidiary, alongside affirming the holding company’s ‘BBB+’ Long-Term Issuer Default Rating. The affirmation praised Enact’s highly favorable company profile, its massive PMIERs coverage ratio, and the structural decoupling from the weaker credit profile of its majority parent, Genworth Financial.
May 05, 2026Q1 2026 Earnings Release
Description: The company demonstrated exceptional resilience against housing affordability headwinds, reporting a GAAP net income of $168 million and an adjusted operating return on equity of 12.9%. Management highlighted that while mortgage originations remained subdued, the primary persistency rate remained elevated at 80%, sustaining the record $272 billion insurance-in-force portfolio.
August 05, 2026Q2 2026 Earnings Release
Description: Enact delivered a blowout quarter, posting adjusted operating income of $177 million ($1.26 per share), comprehensively beating the consensus estimate of $1.19. The market was particularly encouraged by a massive 15% year-over-year surge in new insurance written, which reached $15.2 billion. The stellar credit performance, highlighted by a 50% cure rate on delinquencies, prompted management to confidently raise the 2026 full-year capital return guidance to a range of $550 million to $600 million.
Q1-A6. Step 1 Key Takeaways
Step 1 Summary: Enact Holdings is a highly optimized, enormously profitable financial fortress embedded within the U.S. mortgage oligopoly, uniquely positioned to convert stable insurance premiums into massive, uninterrupted shareholder capital returns through elite risk management and credit risk transfer operations.
Top 3 Red Flags:
1 The fundamental business model is hyper-cyclical; it is structurally bound to the health of the U.S. labor market, where a sudden, severe spike in national unemployment would instantly trigger catastrophic reserving events and erode profitability.
2 The macro environment of generational housing unaffordability and structurally higher mortgage rates acts as a permanent ceiling on origination volumes, meaning Enact is currently relying on portfolio persistency rather than true organic volume growth.
3 The suffocating 81% controlling ownership stake held by Genworth Financial severely constricts the stock’s trading float, eliminates minority shareholder influence, and poses a perpetual overhang risk should Genworth require emergency liquidity.
Top 5 Key Financial/Operational Indicators for Next-Level Analysis:
1 PMIERs Sufficiency Ratio and Excess Capital ($)
2 Primary Insurance In-Force (IIF) Expansion
3 Persistency Rate Trends
4 Loss Ratio and Favorable Reserve Development
5 Volume of Share Repurchases vs. Outstanding Float
Top 3 Unconfirmed and Estimated:
1 The ultimate macroeconomic trajectory of the U.S. housing market over the next 12-18 months, specifically regarding whether a “soft landing” will successfully unlock frozen home inventory.
2 The exact timeline and severity of the default curve for the 2023 and 2024 mortgage vintages as they age into their peak historical delinquency windows.
3 The long-term strategic intentions of Genworth Financial regarding a potential spin-off, secondary offering, or outright sale of its remaining majority stake in Enact.
🏰 Step 2: Enact’s Economic Moat, Growth & Capital Allocation
Q2-A1. Does Enact Have a Durable Economic Moat?
Entry barriers: The private mortgage insurance landscape boasts some of the most impenetrable barriers to entry in the modern financial sector. Following the 2008 financial crisis, the GSEs and the Federal Housing Finance Agency (FHFA) implemented the Private Mortgage Insurer Eligibility Requirements (PMIERs). This draconian regulatory framework demands that any active mortgage insurer hold billions of dollars in highly liquid, strictly defined available assets to support their risk-in-force. A new entrant would require billions in immediate, dead-money capital just to receive authorization to write a single policy. Furthermore, achieving the requisite “A-” credit ratings from agencies like S&P and Moody’s to satisfy lender counterparty requirements is virtually impossible for an unseasoned startup without an established track record of through-cycle underwriting.
Network effects and Switching costs: Enact benefits profoundly from deep operational entrenchment. The company’s proprietary pricing APIs and digital underwriting platforms are hard-coded into the loan origination systems (LOS) of over 1,600 national and regional lenders. For a mortgage originator, efficiency, speed-to-close, and absolute certainty of execution are paramount. The operational friction, IT expenditure, and compliance risks associated with ripping out Enact’s infrastructure to test an unproven competitor create immense switching costs that virtually guarantee high customer retention.
Pricing power: Unlike consumer software, Enact operates in a commoditized financial arena where pricing is dictated by sophisticated, real-time “black box” risk-based pricing (RBP) engines. The pricing is highly transparent among the six oligopoly participants. Enact does not possess unilateral pricing power; arbitrarily raising premiums would result in an immediate, catastrophic loss of market share as lenders effortlessly route loans to Radian or Essent. However, the rational nature of the oligopoly structure acts as a collective moat. Because all six players are heavily scrutinized by the exact same PMIERs capital constraints and rating agencies, destructive, margin-erasing price wars are heavily discouraged, allowing the entire cohort to maintain highly attractive, risk-adjusted underwriting margins.
Moat Conclusion: Enact exhibits a powerful Narrow Economic Moat. While the product itself is commoditized, the insurmountable regulatory capital walls, profound technological integration with lenders, and a disciplined oligopoly structure thoroughly protect the company’s ability to generate structural excess returns on equity over full macroeconomic cycles.
Q2-A2. Is Enact’s Growth Sustainable?
Industry Structure and Market Growth: Enact operates within the mature, highly cyclical U.S. housing finance sector. The Total Addressable Market (TAM) for private mortgage insurance is exclusively determined by the volume of conventional mortgage originations, specifically targeting first-time homebuyers who lack the liquidity for a 20% down payment. Currently, the market is suffocating under the weight of a generational affordability crisis. With 30-year fixed mortgage rates hovering around 6.5% to 7.0%, existing homeowners are trapped by a “lock-in effect,” refusing to sell properties financed at sub-4% rates. This dynamic severely constricts housing inventory, artificially inflating home prices and effectively pricing out the very cohort (first-time buyers) that requires Enact’s insurance. Consequently, structural top-line growth is virtually paralyzed.
Growth Sustainability: Despite the suppression of New Insurance Written (NIW), Enact’s fundamental revenue growth has been sustained through a unique macroeconomic artifact: record-high persistency. The persistency rate measures the percentage of policies that remain active over a 12-month period. Historically hovering around 60%, Enact’s primary persistency rate remained at a staggering 80% through Q2 2026. Because high rates prevent borrowers from refinancing out of their mortgage insurance, Enact’s existing $274 billion Insurance-In-Force (IIF) portfolio remains highly sticky, generating massive, recurring premium revenue without the acquisition costs of new business. However, this growth mechanism is fragile; it is entirely dependent on rates remaining elevated.
Downside Scenarios:
1 The Mass Refinancing Cliff: If the Federal Reserve aggressively cuts interest rates to combat economic slowing, mortgage rates could plunge. This would instantly trigger a massive wave of refinancing. Borrowers would refinance out of their high-rate mortgages, immediately canceling their Enact PMI policies. The 80% persistency rate would collapse, rapidly eroding the IIF portfolio before new purchase originations could replenish the lost revenue.
2 Labor Market Collapse: The primary driver of mortgage defaults is unemployment, not home equity. A severe, prolonged recession causing a spike in national unemployment would trigger a devastating wave of borrower delinquencies. This would instantly reverse the current trend of massive reserve releases, forcing Enact to aggressively provision for losses, wiping out net income, and severely damaging its PMIERs capital cushion.
3 Regulatory Crowding-Out: The Federal Housing Administration (FHA) could aggressively slash its mortgage insurance premiums (MIP) to capture market share, or the GSEs could alter their Loan-Level Price Adjustments (LLPAs) in a way that penalizes private capital, structurally shrinking the TAM available to the private oligopoly.
Q2-A3. How Does Enact Allocate Capital & Return Cash?
Priorities and consistency: Enact’s management operates one of the most disciplined, shareholder-friendly capital allocation engines in the financial sector. Recognizing the futility of chasing unprofitable market share in a stagnant housing market, management explicitly prioritizes capital sufficiency first, followed by aggressive, highly accretive returns to shareholders. The company does not engage in reckless M&A or speculative horizontal expansion. Instead, the organic cash flow generated from the in-force book is methodically upstreamed from the operating subsidiary (EMICO) to the holding company to fund a dual-pronged return strategy: a steady quarterly dividend and a relentless share repurchase program.
Reinvestment and Reinsurance Mastery: Enact’s most brilliant capital allocation maneuver is its sophisticated use of Credit Risk Transfer (CRT). Rather than hoarding excess capital to cover tail-risk catastrophic losses, Enact routinely syndicates the mezzanine tranches of its risk to global capital markets. Through its Triangle Re Insurance-Linked Note (ILN) platform—such as the $248 million Triangle Re 2023-1 issuance—and traditional excess-of-loss (XOL) treaties, Enact transfers catastrophic loss exposure to third-party investors. This alchemy dramatically reduces the company’s required assets under the PMIERs framework, freeing up hundreds of millions in trapped capital that is immediately redirected into stock buybacks.
Shareholder Return Assessment: The execution of this strategy is flawless. In 2025 alone, Enact returned over $500 million to shareholders ($121 million in dividends, $382 million in repurchases). In early 2026, the Board authorized a massive new $500 million repurchase program. With the stock chronically trading near 10.4x earnings and at roughly a 25% premium to book value, buying back shares is massively accretive to EPS and intrinsic value per share. The company raised its 2026 capital return guidance to $550-$600 million, mathematically guaranteeing that investors will receive a double-digit yield on current market capitalization through a combination of buybacks and cash dividends.
Q2-A4. Step 2 Key Takeaways
Scoring Rationale:
Economic Moat (8/10): The industry is an impenetrable fortress protected by GSE-mandated PMIERs capital requirements, deep technological lender integrations, and a highly rational oligopoly structure that inherently prevents margin-destroying competition.
Growth Sustainability (5/8): Top-line premium growth is effectively paralyzed by a frozen macro housing market; the company relies heavily on an artificially inflated persistency rate, which will inevitably face severe headwinds once interest rates eventually normalize.
Capital Allocation (7/7): Management executes a masterclass in financial engineering, perfectly utilizing CRT markets to offload tail risk while funneling the resulting excess capital into a massive, highly accretive share cannibalization program.
Step 2 Summary: Enact controls a highly defensible, moat-protected franchise that, while currently starved of organic top-line volume growth due to macro constraints, compensates investors immensely through elite capital management, risk offloading, and aggressive cash returns.
💰 Step 3: Is Enact Profitable? Financial Health Analysis
Q3-A1. Enact’s Growth & Profitability Trends
Revenue and Earnings Trajectory: Over the past five years, Enact has demonstrated remarkable top-line stability. Total revenues have scaled from $1.12 billion in 2021 to a TTM figure of $1.24 billion as of mid-2026. This stability masks an explosive acceleration in bottom-line per-share metrics. While total net income has hovered remarkably steady—$666 million in 2023, $688 million in 2024, and $674 million in 2025—the company’s diluted earnings per share (EPS) have consistently drifted upward ($4.11 in 2023, $4.37 in 2024, $4.52 in 2025) solely due to the mechanical destruction of outstanding shares via buybacks.
Investment Income Surge: A critical, often overlooked driver of recent profitability has been the rapid expansion of net investment income. Enact’s $6.2 billion investment portfolio has immensely benefited from the “higher for longer” interest rate environment. Net investment income surged from $207 million in 2023 to $241 million in 2024, and reached $266 million in 2025. In Q2 2026, it hit $73 million for the quarter alone, providing a massive, non-underwriting profit stream that directly subsidizes the bottom line.
Operating Leverage and Margins: The company boasts a spectacular structural profit margin. Operating expenses are meticulously controlled, resting at $52 million in Q2 2026, creating an incredibly lean expense ratio of just 21%. Because the digital underwriting engines and risk analytics platforms scale perfectly, Enact can process billions in new insurance written without materially increasing headcount or physical footprint. This operating leverage ensures that the vast majority of net earned premiums flow directly to operating income.
Q3-A2. How Profitable Is Enact? (Margins & ROIC)
Return on Equity (ROE): As a highly regulated insurance entity, Enact’s balance sheet is dominated by financial reserves and investment securities. Traditional Return on Invested Capital (ROIC) frameworks are entirely inappropriate, as debt is minimal and operational assets are negligible. Instead, capital efficiency is strictly measured by Return on Equity (ROE). Enact consistently generates elite returns. For the full year 2025, ROE stood at 13.0%, with Adjusted Operating ROE at 13.3%. Through Q2 2026, the company maintained this elite pace, generating a 13.0% ROE and a 13.2% Adjusted Operating ROE.
Cost of Equity Spread: With a typical cost of equity (COE) for a mature financial modeled between 9.0% and 10.0%, Enact is consistently generating a 300 to 400 basis point spread over its cost of capital. This represents the creation of genuine, sustainable economic value. The company’s profitability is fundamentally anchored by the pristine credit quality of its underlying insured portfolio; as of Q2 2026, an astonishing 61% of risk-in-force originated with FICO scores above 740, and the high-risk layered loans (high LTV combined with sub-680 FICO) constitute a negligible 1.1% of the book.
Q3-A3. What Drives Enact’s Returns? (ROIC Breakdown)
Alternative Metric Selection: For a private mortgage insurer, operational efficiency is exclusively driven by the Combined Ratio, which is the sum of the Loss Ratio (claims paid and reserved divided by earned premiums) and the Expense Ratio (operating costs divided by earned premiums).
Loss Ratio Dynamics: The Loss Ratio is the single most volatile and critical driver of Enact’s profitability. In 2024, the full-year loss ratio was an unbelievably low 4%. In 2025, it normalized slightly to 11%. In Q2 2026, the loss ratio stood at a highly manageable 14%. These suppressed loss ratios are heavily subsidized by favorable prior-period reserve development. When a borrower becomes delinquent, Enact must immediately establish a loss reserve. However, due to unprecedented home price appreciation (HPA) and a robust labor market, the vast majority of these delinquent borrowers are either curing on their own or selling their homes profitably to pay off the mortgage, avoiding a claim. This “cure rate” hit an incredibly high 50% in Q2 2026. Consequently, the reserves previously set aside are released back into earnings. For example, Enact enjoyed a $60 million pre-tax net reserve release in Q4 2025 and a $37 million release in Q2 2026.
Expense Ratio Efficiency: The expense ratio acts as a highly stable anchor, consistently hovering between 20% and 24% over the past three years. In Q2 2026, the expense ratio was a lean 21%, highlighting management’s absolute control over SG&A costs. When combined with the suppressed loss ratios, Enact frequently operates with a Combined Ratio in the mid-30% range (e.g., 33.4% in 2025), generating massive underwriting profits.
Q3-A4. Are Enact’s Earnings High Quality?
Cash Flow and Earnings Backing: Enact’s earnings are of the highest possible quality. The mortgage insurance business model is structurally cash-flow positive; premiums are collected entirely in cash on a monthly basis, while claim payouts are delayed by months or years due to lengthy foreclosure timelines. There are no complex, non-cash mark-to-market revenue adjustments artificially inflating the top line. The company’s net income maps flawlessly to tangible statutory capital generation.
Reserve Adequacy and Favorable Development: The persistent trend of favorable reserve releases proves that management operates with extreme conservatism when initially provisioning for delinquent loans. By over-reserving during the onset of a delinquency and subsequently releasing the excess cash back into earnings as the borrower cures, the company ensures its balance sheet is continuously insulated against downside shocks. However, investors must recognize that these reserve releases represent a cyclical peak; as the 2022-2024 vintages age and the cure rate normalizes downward from 50%, the loss ratio will inevitably climb, presenting a future headwind to earnings growth.
Q3-A5. Is Enact’s Balance Sheet Healthy? (Debt & Leverage)
PMIERs Capital Sufficiency: Enact’s balance sheet is an absolute fortress, engineered to withstand a macroeconomic apocalypse. The ultimate arbiter of financial health is the PMIERs sufficiency ratio. As of Q2 2026, Enact boasted a PMIERs sufficiency ratio of 161%. This means the company holds an astonishing $1.89 billion in available, liquid assets directly above the strictest regulatory minimums mandated by the GSEs. This massive buffer ensures that even if unemployment were to double overnight, Enact would remain fully capitalized and operational without needing to raise dilutive external equity.
Investment Portfolio Security: The $6.2 billion asset portfolio backing these reserves is bulletproof. The portfolio is 99% investment grade, heavily concentrated in highly liquid securities: 32% AAA, 30% A, and 29% AA. The composition includes 45% U.S. Corporate Bonds, 16% CMBS, and minimal exposure to esoteric or illiquid alternative investments.
Leverage and Holding Company Liquidity: Financial leverage is modest and declining. The holding company leverage ratio (excluding AOCI) was reduced to 13.8% at year-end 2025. Enact Holdings maintains ample standalone liquidity (over $250 million in cash) at the holding company level to comfortably service its debt and fund operations, subsidized entirely by the continuous, massive dividend upstreaming from the primary operating subsidiary (EMICO).
Q3-A6. Step 3 Key Takeaways
Scoring Rationale:
Profitability·Capital Efficiency (9/10): Enact routinely generates a highly resilient, low-teens Return on Equity and operates with a pristine combined ratio in the mid-30% range, establishing elite capital efficiency, though structural top-line growth remains capped.
Cash Flow·Profit Quality (8/8): Earnings are completely backed by upfront statutory premium cash flows, and extreme reserving conservatism is validated by continuous, massive favorable prior-year developments.
Financial Soundness·Debt Management (7/7): A colossal 161% PMIERs sufficiency ratio ($1.89B excess), a $6.2B investment-grade portfolio, and brilliant CRT offloading create an utterly unbreakable balance sheet.
Step 3 Summary: Enact’s financial health is immaculate, characterized by dominant underwriting margins, massive regulatory capital buffers, and an asset portfolio virtually immune to liquidity crises, providing the perfect foundation for aggressive shareholder returns.
Evidence: Premiums are earned systematically over the precise life of the underlying mortgage policy in strict accordance with stringent statutory and GAAP insurance accounting standards; there is absolutely no aggressive front-loading or fabrication of unearned premium revenues.
Cost capitalization: not found
Evidence: Policy acquisition costs are deferred and amortized mechanically, perfectly matching the duration of the related premium revenue. There is zero evidence of management artificially extending amortization schedules to suppress current-period expenses and inflate earnings.
Sharp increase in accounts receivable and inventory: not found
Evidence: The concept of physical inventory is non-existent in the financial sector. The equivalent metric—premium receivables—remains completely stable, perfectly proportional to the slow, steady expansion of the $274 billion insurance-in-force book.
Non-recurring adjustment (normalization): not found
Evidence: While the company frequently records massive benefits from favorable reserve releases (e.g., $37 million in Q2 2026), these are a standard, transparent, and unavoidable part of the cyclical mortgage insurance reserving process, not deceptive “one-time” adjustments designed to mask operational deterioration.
Q4-A2. Is Enact Overspending? (Capex & Capital Cycle)
➖ Not applicable: The capital cycle and oversupply lens does not apply to the private mortgage insurance business structure, which relies entirely on regulatory capital limits, credit risk transfer, and financial reserving rather than cyclical physical capital expenditures or manufacturing capacity expansion.
Q4-A3. How Sound Is Enact’s Cash Flow?
Cash flow stability: Operating cash flow is exceptionally robust, fundamentally anchored by the prepaid nature of monthly mortgage premiums. The company requires zero external debt financing or dilutive equity raises to fund its core operations.
Earnings backing and dependency: Net income maps flawlessly to statutory capital generation. The primary operating entity, Enact Mortgage Insurance Corporation (EMICO), possesses such massive excess capital that it continuously dividends hundreds of millions of dollars upstream to the holding company (Enact Holdings, Inc.). This organic cash pipeline is the sole fuel required to entirely fund the company’s aggressive $500 million share repurchase program and its quarterly cash dividends.
Q4-A4. Is Enact Diluting Shareholders?
Confirmed (Past) Dilution: Enact is the ultimate anti-dilution machine. The company is actively and aggressively cannibalizing its own equity base. Over the past few years, the relentless buyback program has caused the outstanding share count to plummet. By early 2026, shares outstanding had been crushed down to 137.48 million. In 2025 alone, the company retired 10.5 million shares. This aggressive destruction of float is mathematically supercharging Earnings Per Share (EPS) and Book Value Per Share, completely offsetting the stagnation in top-line revenue growth.
Potential (Future) Dilution & Overhang: Stock-based compensation (SBC) is completely negligible compared to the velocity of the buybacks. The only structural overhang on the stock is the massive 81% controlling stake held by the parent company, Genworth Financial. While Genworth is not diluting Enact, it systematically participates in the share repurchase program—selling shares directly back to Enact to keep its ownership percentage perfectly locked at 81.6%. Should Genworth ever face extreme distress and attempt to liquidate this 111.6 million share block into the open market, it would create catastrophic, insurmountable supply overhang.
Definition: GAAP EPS, Adjusted Operating Income, and PMIERs sufficiency definitions consistently unified across all SEC filings and investor presentations ➡ (Pass)
Number of shares: Diluted shares outstanding consistently utilized for EPS and valuation multiples, accurately reflecting the rapid share reduction ➡ (Pass)
Unit: USD standard applied universally across all revenue, asset, and market capitalization metrics ➡ (Pass)
Single Value Confirmation: A single, verified source of truth was achieved across all complex financial ratios, reserve release figures, and CRT execution data ➡ (Pass)
Q4-A6. Step 4 Key Takeaways
Scoring Rationale:
Accounting anomalies·distortion signals (8/8): The financial statements are impeccably clean, transparent, and subjected to exhaustive scrutiny by the SEC, state insurance regulators, and the GSEs.
Cash flow warning signals (7/7): Cash generation is massive, highly predictable, and structurally insulated by the prepaid nature of the mortgage insurance model.
Dilution factors (5/5): The company is an aggressive cannibal of its own stock, systematically destroying millions of shares quarterly, establishing a permanent anti-dilutive force that rapidly accelerates per-share intrinsic value.
Step 4 Summary: Enact exhibits flawless accounting integrity and operates a highly accretive capital structure where aggressive, cash-funded buybacks act as a constant, mathematical tailwind for minority shareholders.
Q5-A1. Can You Trust Enact’s Management? (Guidance Track Record)
Guidance Hit Rate: Under the leadership of President and CEO Rohit Gupta, Enact’s management team has established a flawless track record of under-promising and over-delivering. In Q2 2026, the company posted an adjusted EPS of $1.26, easily beating the consensus estimate of $1.19. Furthermore, management consistently meets or exceeds its capital return targets; following the Q2 2026 beat, they confidently raised the 2026 full-year capital return guidance to an impressive $550-$600 million range (up from a baseline of $500 million).
Transparency and Consistency: Management operates with exceptional transparency, providing granular quarterly disclosures on PMIERs sufficiency ratios, specific cure and delinquency rates, FICO distributions, and precise details regarding their complex Triangle Re CRT ILN issuances. When discussing headwinds—such as the inevitable normalization of the historically low loss ratio as the 2023 vintages age—management is highly forthcoming, avoiding the temptation to over-promise perpetual zero-loss environments.
Q5-A2. What Are Enact Insiders Doing?
Insider Trading Status and Context Analysis: Independent insider trading activity is relatively routine and minimal, primarily consisting of standard stock-based compensation vesting and subsequent programmed tax-withholding sales. For example, EVP & COO Brian Gould recently filed an intent to sell a modest 23,000 shares (valued at roughly $952k), which represents a routine portfolio balancing maneuver rather than a mass executive exodus. Over the last 12 months, company insiders have collectively sold approximately $9.1 million more than they bought, a standard dynamic for a mature financial firm where equity forms a large portion of executive compensation.
The Genworth Dynamic: The dominant “insider” is the parent company, Genworth Financial, holding 111.6 million shares (81% ownership). Genworth utilizes Enact as a critical cash engine. Through a dedicated Share Repurchase Agreement, whenever Enact buys back shares on the open market, Genworth proportionally sells a corresponding block of shares directly back to Enact. For instance, Genworth recently sold 820,567 shares directly to Enact at $40.92, ensuring its ownership precisely maintained the 81.6% threshold. This allows Genworth to extract massive liquidity—receiving $127 million in Q4 2025 alone—to service its own holding company debt, without flooding the open market and crushing Enact’s stock price.
Q5-A3. Is Enact’s Management Aligned With Shareholders?
Voting Rights and Governance: Because Genworth Financial controls over 80% of the voting power, Enact is officially designated a “controlled company” under NASDAQ rules. Consequently, minority shareholders are entirely disenfranchised. They possess zero power to influence board composition, alter strategic direction, or force a hostile M&A transaction. The minority float exists entirely at the mercy of Genworth’s strategic imperatives.
Performance and Compensation Indicator (KPI) Analysis: Despite the controlled status, Enact’s executive compensation KPIs are brilliantly designed. Incentives are heavily anchored to Adjusted Operating ROE and the preservation of the PMIERs capital buffer. This ensures management is not incentivized to recklessly chase top-line market share by underwriting toxic, sub-prime loans (which would destroy the loss ratio). Instead, they are perfectly aligned with preserving the book value, offloading tail-risk via CRT, and shrinking the equity base to drive up ROE.
Tax Sharing Agreement: Enact operates under a consolidated tax sharing agreement with Genworth. While all intercompany balances are settled annually, this structural entanglement reinforces the reality that Enact is fundamentally bound to the financial machinations of its parent company.
Q5-A4. Step 5 Key Takeaways
Scoring Rationale:
Management Trust (5/5): Impeccable execution on massive capital return frameworks, flawless CRT syndication, and continuous outperformance against conservative Wall Street consensus models.
Insider Trends (4/5): Routine executive sales are immaterial, but Genworth’s relentless mechanical selling to extract liquidity acts as a constant ceiling on the score.
Governance·Compensation System (4/5): Compensation KPIs are perfectly aligned with intrinsic value creation, but the “controlled company” status fundamentally and permanently disenfranchises minority voting rights.
Step 5 Summary: Enact is guided by an elite, highly competent management team perfectly incentivized to maximize ROE and capital efficiency, though investors must soberly accept the reality of operating as powerless minority partners to Genworth Financial.
⛵ Step 6: Enact Market Flow & Sentiment
Q6-A1. Analyst Consensus vs Enact Guidance
Guidance gap and direction analysis: The analyst community remains chronically behind the curve of Enact’s actual fundamental velocity. In Q2 2026, the company posted an adjusted EPS of $1.26, blowing past the consensus estimate of $1.19. Despite this relentless outperformance, the average analyst price target is stuck at a remarkably conservative $50.20, implying a meager +0.78% upside from current levels.
Tracking recent sentiment changes: Sentiment is paralyzed by macroeconomic anxiety. Prominent institutions have recently initiated or maintained neutral coverage; RBC Capital initiated coverage with a Hold and a $46.00 target, while JPMorgan and Keefe, Bruyette & Woods (KBW) maintain Hold ratings with targets of $48.00 and $49.00 respectively. Analysts universally acknowledge the company’s elite profitability, but they refuse to model multiple expansion, stubbornly anticipating that the “higher for longer” interest rate environment will eventually destroy the housing market and trigger a spike in default loss ratios.
Q6-A2. What Is Enact’s Short Interest?
Institutional Trends: The extreme 81% concentration of ownership by Genworth Financial leaves a highly restricted public float of roughly 19%. This tiny free float actively deters massive institutional accumulation, as large mutual funds cannot build meaningful positions without severely distorting the daily price. Nevertheless, quantitative and value-focused funds like BlackRock (3.34%) and Dimensional Fund Advisors (2.15%) maintain positions to capture the massive cash yield.
Short Selling Indicators: Short interest is notably aggressive relative to the restricted float. As of mid-2026, short interest sits at 13.55% of the float, accompanied by a staggering 17.9 Days-to-Cover ratio. Furthermore, off-exchange short volume accounts for a massive 53.91% of trading. This data clearly indicates that hedge funds are using Enact as a proxy vehicle to short the broader U.S. housing market and the consumer credit cycle. Given the tiny float and the 17.9 days required to cover, any sudden, unexpected positive macroeconomic catalyst (e.g., a massive dovish pivot by the Federal Reserve) could theoretically trigger a devastating, slow-burn short squeeze.
Q6-A3. Step 6 Key Takeaways
Scoring Rationale:
Consensus vs Guidance (3/3): The company continues to systematically crush highly conservative Wall Street estimates, driven by prolonged, unexpected reserve releases and relentless share count reduction.
Supply·Short Interest (1/2): A severely restricted free float combined with an aggressive 13.55% short interest introduces significant structural volatility risk, while the broader analyst community remains stubbornly anchored to “Hold” ratings.
Step 6 Summary: Market sentiment is locked in a fierce tug-of-war; Enact’s flawless internal execution and massive cash generation are entirely overshadowed by deep-seated institutional pessimism regarding the macro housing cycle, resulting in a compressed valuation and elevated short interest.
🚀 Step 7: Enact Catalysts & Price Triggers
Q7-A1. What Could Move Enact Stock? (Top 3 Catalysts)
1 Accelerated Implementation of the $500M Buyback Authorization
Timing: Next 6-12 months
Success Conditions: Management aggressively deploys the newly authorized $500M share repurchase program at the current undervalued 10.4x P/E multiple. By destroying roughly 7% of the total outstanding float, management mathematically forces Earnings Per Share (EPS) and Book Value Per Share significantly higher, establishing an ironclad price floor regardless of stagnant top-line revenue growth.
Failure Risk: Severe macroeconomic deterioration or an unexpected spike in borrower delinquencies forces management to halt all buyback activity to preserve the PMIERs capital buffer, instantly removing the stock’s primary support mechanism and disappointing yield-focused investors.
2 Structural Resolution of the Genworth Financial Overhang
Timing: Next 12-24 months
Success Conditions: Genworth Financial finally executes a clean spin-off of its remaining 81% stake (111.6 million shares) to its own shareholders or negotiates a block sale to a massive strategic acquirer. This instantly removes the “controlled company” discount, drastically increases daily trading liquidity, and opens the door for mandatory, price-insensitive buying by mid-cap and financial sector ETFs.
Failure Risk: Genworth’s legacy Long-Term Care (LTC) insurance blocks suffer catastrophic reserving shortfalls, forcing regulators to mandate a distressed, uncoordinated liquidation of the Enact stake into the open market to raise emergency capital, flooding the market with supply and crushing Enact’s stock price.
3 A Soft Landing Driving a Resurgence in Mortgage Originations
Timing: Next 6-12 months
Success Conditions: The Federal Reserve perfectly engineers a macroeconomic soft landing; mortgage rates slowly drift downward to the 5.5% to 6.0% range. This unlocks pent-up housing supply, breaking the “lock-in effect” and triggering a wave of new home purchases by first-time buyers. This dramatically accelerates Enact’s New Insurance Written (NIW) volume without sacrificing the pristine 740+ FICO credit quality of the book.
Failure Risk: Mortgage rates plummet too quickly (e.g., dropping below 4.5%), triggering a massive, uncontrolled wave of refinancing. Borrowers refinance out of their existing PMI policies, instantly collapsing Enact’s highly profitable 80% persistency rate and wiping out the $274 billion insurance-in-force book faster than new purchase volume can replace it.
Q7-A2. Enact’s Earnings Revision Trend
Tracking EPS estimate changes: Wall Street analysts have been forced into a continuous, begrudging upward revision cycle. Because analysts chronically overestimate the speed at which the loss ratio will normalize and continuously underestimate the raw mathematical power of the share buybacks, they are forced to revise EPS estimates upward following nearly every quarterly print. The recent Q2 2026 beat ($1.26 actual vs $1.19 consensus) serves as the latest inflection point, forcing models to incorporate the raised $550-$600 million capital return guidance.
Earnings expectations and momentum assessment: The earnings momentum is structurally positive but low-volatility. The market perpetually prices in a severe housing correction that has yet to arrive. Therefore, Enact’s mechanical, drama-free execution—collecting premiums, releasing reserves from cured delinquencies, and buying back stock—creates a continuous, reliable beat-and-raise environment that slowly bleeds short sellers.
Q7-A3. Step 7 Key Takeaways
Scoring Rationale:
Catalyst (5/7): The aggressive execution of the $500M buyback and the potential for macro easing are highly actionable, upside-driving catalysts, though the Genworth ownership overhang remains a massive, unpredictable variable.
EPS Trend (3/3): The analyst community remains chronically behind the curve, resulting in a reliable, continuous upward revision cycle following every earnings announcement as reality outperforms conservative modeling.
Step 7 Summary: The stock is tightly coiled; the continuous, aggressive share cannibalization provides an ironclad baseline floor, while any normalization in housing turnover or the eventual resolution of the Genworth controlling stake serves as a massive, asymmetrical upside trigger.
⚖️ Step 8: Is Enact Fairly Valued? Valuation Analysis
Scoring Rationale: Enact’s absolute valuation multiples are inherently cheap, reflecting the perpetual “financial monoline” discount. Trading at just 10.41x trailing earnings while generating a 13.0% ROE represents a highly attractive absolute price relative to current cash generation and the massive dividend/buyback yield.
📌 (1) Axis Q8-A1 Score:+3
Q8-A2. Enact vs Peers: Valuation Comparison
Multiple selection based on peer comparison: Forward PER
Scoring Rationale: Enact trades at exactly 10.0x forward earnings, completely identical to the 10.0x peer average (which includes tightly correlated oligopoly rivals like Radian, Essent, and MGIC). This perfect alignment places the company squarely within the Fairly Valued (-10% to +10%) band relative to its immediate competitors.
📌 (2) Axis Q8-A2 Score:0
Q8-A3. Is Enact Cheap or Expensive vs Its History?
Comparison Indicators: Trailing PER
Scoring Rationale: Since its September 2021 IPO, Enact has historically commanded heavily depressed multiples, frequently hovering in the 6.0x to 8.0x range due to pandemic-era housing fears. The current 10.41x multiple places the stock in the extreme upper decile of its brief public history, screening mechanically as overvalued relative to its own post-IPO historical baseline.
📌 (3) Axis Q8-A3 Score:-2
Q8-A4. What Growth Is Priced Into Enact? (Reverse DCF)
Implied Growth Rate:-2.5%
1 Methodology: Simplified PEG-based inversion matched to a 10.4x P/E on a mature, regulated financial entity.
2 Core assumptions: Assumes a terminal cost of equity (COE) of 10% with 100% of the earnings base backed by statutory cash generation from the existing insurance-in-force.
Achievable Growth Rate:+2.0%
Basis: Long-term analyst consensus models essentially flat to low-single-digit fundamental net income growth, as the structural stagnation in mortgage origination volume is perfectly offset by the mathematically guaranteed EPS accretion derived from the $500 million share repurchase program.
Scoring Rationale: The market is actively pricing in negative perpetual growth. The arithmetic certainty of the massive share buybacks alone guarantees low-single-digit EPS expansion, rendering the market’s implied negative hurdle rate absurdly easy to clear, indicating deep undervaluation.
(3) Axis Q8-A3 (Historical Band Position): Overvalued (-2)
(4) Axis Q8-A4 (Justification for Growth): Undervalued (+2)
A classic split verdict emerges from the data: absolute metrics and exceedingly low growth hurdles suggest undervaluation, while historical band positioning flags the stock as overvalued compared to its own post-IPO trough, resulting in a mechanical failure to reach a three-axis consensus.
📌 (5) Axis Q8-A5 Score:-2
Q8-A6. Enact’s Hidden Asset & Stake Valuation
➖ Not applicable: (Not applicable)
📌 (6) Axis Q8-A6 Score:➖
Q8-A7. Final Valuation Adjustment
Scoring Rationale: No exceptional macroeconomic paradigm shifts or hidden off-balance-sheet assets exist that would warrant overriding the mechanical valuation matrix. The business model is highly transparent, and its economic reality is appropriately and fully captured by the standard valuation axes.
Commentary: The mechanical valuation framework yields a perfectly neutral result. The company’s severe undervaluation on an absolute cash-flow basis is entirely counterbalanced by the reality that it is currently trading near the absolute peak of its brief post-IPO historical valuation band, confirming it is fairly priced within current market parameters.
Step 8 Summary: Enact is fundamentally cheap on an absolute basis but appropriately priced within its immediate peer group, offering investors a massive margin of safety regarding growth expectations while trading at cyclical highs for its specific historical multiple.
💀 Step 9: What Are the Risks of Enact? Fatal Risks & Pre-Mortem
Q9-A1. What Are the Biggest Risks to Enact?
1 Severe Macroeconomic Recession and Unemployment Spike:
Cause: The Federal Reserve fails to engineer a soft landing, plunging the United States economy into a deep, prolonged recession characterized by severe, sustained job losses across multiple sectors.
Impact: financial (A massive spike in mortgage defaults overwhelms current loss reserves, completely wiping out net income, halting all capital returns, and triggering severe statutory capital deterioration).
Mitigation/Monitoring Indicators: U.S. Bureau of Labor Statistics monthly unemployment rate reports; Enact’s monthly internal new delinquency rate metrics (currently stable at 1.3%).
2 Structural Risk from Genworth Financial’s 81% Controlling Stake:
Cause: Genworth Financial faces a sudden, catastrophic liquidity crisis regarding its legacy Long-Term Care (LTC) insurance portfolio, forcing regulators to mandate an uncoordinated, distressed liquidation of Genworth’s 81% stake in Enact to raise emergency capital.
Impact: multiple (An unprecedented flood of institutional supply crushes the stock price, completely decoupling the equity valuation from Enact’s actual, pristine operating performance).
Mitigation/Monitoring Indicators: Genworth Financial’s quarterly Risk-Based Capital (RBC) ratios and statutory pre-tax income disclosures regarding its legacy life and LTC blocks.
3 Regulatory Alteration of GSE Pricing or PMIERs Requirements:
Cause: The Federal Housing Finance Agency (FHFA) unilaterally alters pricing grids (LLPAs) or GSE guarantee fees in a manner that renders private mortgage insurance economically uncompetitive compared to FHA alternatives, or institutes punitive new PMIERs capital thresholds.
Impact: financial (Permanent, structural destruction of the Total Addressable Market (TAM) for New Insurance Written, severely capping long-term top-line growth).
Mitigation/Monitoring Indicators: FHFA policy announcements, PMIERs guidance updates, and quarterly GSE market share vs. FHA origination data.
Q9-A2. How Sensitive Is Enact to the Economy?
1 U.S. Interest Rate Environment (⬇): A rapid, steep drop in 30-year mortgage rates would trigger a massive, uncontrollable wave of refinancing. This would instantly collapse Enact’s currently elevated 80% persistency rate, rapidly cannibalizing the highly profitable existing $274 billion insurance-in-force portfolio faster than new originations could replace it (sales/margin).
2 U.S. Unemployment Rate (⬆): A sharp spike in the national unemployment rate acts as the single most lethal variable for any mortgage insurer. It instantly converts currently performing loans into active delinquencies, forcing massive, immediate reserving events that destroy quarterly earnings and threaten PMIERs capital buffers (value).
Q9-A3. Enact Pre-Mortem: What Could Go Wrong?
1 The Great Housing Correction Materializes: Affordability reaches a true breaking point, and home prices nationwide plummet 15-20%. This instantly plunges recent 2022-2024 low-down-payment homebuyers into negative equity. Without the ability to profitably sell their homes to cure defaults, claim severities skyrocket, devastating the loss ratio.
Early Warning Signal: The Case-Shiller National Home Price Index registers three consecutive months of severe, accelerating negative growth across major metropolitan areas.
2 Catastrophic Failure of the CRT Reinsurance Market: Global reinsurers and ILN investors, suffering massive losses in other insurance domains, completely exit the mortgage credit risk transfer market. This prevents Enact from executing deals like the $248 million Triangle Re 2023-1. Starved of capital relief, Enact’s PMIERs required assets skyrocket, forcing an immediate, permanent suspension of all buybacks and dividends.
Early Warning Signal: The complete failure of a peer mortgage insurer (e.g., Radian or Essent) to syndicate a new ILN issuance, accompanied by massive spread blowouts in secondary CRT trading.
3 Genworth Forced Liquidation: A state insurance regulatory ruling forces Genworth to instantly capitalize its legacy LTC entities, resulting in the panicked, market-dumping sale of over 100 million Enact shares over a 90-day period.
Early Warning Signal: Genworth files an emergency 8-K disclosing severe statutory capital deficiencies in its life insurance subsidiaries, dropping its RBC ratio below critical regulatory thresholds.
Q9-A4. Risk Adjustment Score
Reason for Scoring: The core macroeconomic and ownership risks are undeniably present and severe. However, management has armored the balance sheet with an impregnable layer of excess capital—holding a 161% PMIERs sufficiency ratio with $1.89 billion in excess assets—and brilliant CRT syndication. Furthermore, the pristine credit quality of the insured book, where 61% of borrowers hold 740+ FICO scores, ensures these risks remain entirely within the realm of manageable, psychological concerns rather than immediate financial impairment.
📊 Risk Adjustment Score:-4 pts
Step 9 Summary: Enact faces legitimate, systemic macroeconomic risks inherent to the highly cyclical U.S. housing market, but the company has meticulously constructed an impenetrable capital fortress of excess reserves and reinsurance to absorb all but the most apocalyptic Black Swan events.
Commentary: The robust final outcome is heavily anchored by the company’s supreme capital efficiency, pristine accounting integrity, and incredibly aggressive shareholder returns. While muted market sentiment and historically high valuation bands apply slight drag, the sheer mathematical power of the $500 million buyback engine and the massive structural regulatory moat propel the company firmly into elite investment territory.
Q10-A2. Should You Buy Enact? (Recommendation)
Recommendation:Buy
Commentary: Enact represents a premier, defensive vehicle for compounding capital in a stagnant housing market. The combination of a highly resilient 13% ROE, massively accretive share repurchases, and an impenetrable PMIERs regulatory moat creates a highly asymmetric risk/reward profile that heavily favors long-term accumulation.
Q10-A3. Investment Thesis in One Line
Enact operates as a highly disciplined, cash-generating fortress within the U.S. mortgage insurance oligopoly, relentlessly compounding per-share value through aggressive buybacks and flawless risk transfer, though investors must tolerate the permanent structural overhang of Genworth’s majority ownership and acute sensitivity to macroeconomic housing shocks.
Q10-A4. Enact’s Price Trend & Key Drivers
Stock Price Trends Over the Past 12 Months:Sideways movement ➡️
February 03, 2026Massive $500M Buyback Authorization Announcement
Description: Alongside strong Q4 2025 earnings, management authorized a staggering $500 million share repurchase program, signaling immense confidence in PMIERs capital sufficiency and instantly establishing an ironclad floor under the stock. ➡ Stock Price Reaction: Stabilized Support
August 05, 2026Q2 2026 Earnings Beat and Guidance Raise
Description: The company completely crushed analyst EPS estimates ($1.26 actual vs $1.19 consensus) due to continued strong cure rates and zero signs of credit deterioration, confidently raising the full-year capital return guidance to $550-$600 million. ➡ Stock Price Reaction: Modest Upward Drift to 52-Week Highs
Q10-A5. Action Plan
Current Price:$49.78
Buy Zone:$47.00 ($45.00–$49.00)
(1) Calculation of Fundamental Value: From the perspective of securing the ‘Margin of Safety,’ entering below the $49.00 threshold ensures investors acquire the asset at a modest premium to intrinsic book value ($39.06 per share) while capitalizing on the 10.4x P/E multiple before further relentless buybacks permanently elevate the baseline floor.
(2) Momentum Premium/Discount Application: Because the stock is currently consolidating near its 52-week highs with an established sideways trend, we demand strict adherence to the conservative intrinsic value, waiting for broader macro volatility or housing data scares to provide an entry within the band rather than chasing breakouts.
(3) Conclusion: The $47.00 midpoint represents the optimal convergence of historical support lines and the current fundamental valuation, offering a highly defensive entry point protected by the company’s aggressive, price-insensitive open-market purchasing.
Price Target:$55.00
Expected Return:+10.5% (vs. current price)
📍 Select target stock price calculation criteria:
Forward PER Multiple — The clearest reflection of Enact’s cash-generation capacity and the standard, universally accepted benchmark utilized across the mortgage insurance oligopoly.
🧮 Price Target Calculation Formula:
Per share indicator based (Forward PER, P/FCF, etc.): $4.81 × 11.43 = $55.00
Basis for applying the multiple: 5-year historical average P/E multiple from Q8 — 11.43x — applying a modest premium to the current 10.4x multiple to reflect Enact’s superior loss ratios, extreme PMIERs capital sufficiency, and the mathematically guaranteed accretion of the $500M share repurchase program.
Conditions and timing for reaching price target: Achievement relies upon the continued flawless execution of the $500 million buyback program destroying active float, combined with the Federal Reserve successfully executing a soft landing over the next 6-12 months that stabilizes housing turnover without causing a spike in national unemployment.
Stop Loss:$39.00 ($38.00–$40.00)
Action trigger upon catalyst achievement:
1 Genworth executes a block sale or spin-off of a significant portion of its 81% stake
Description: This eliminates the single largest structural discount on the stock, drastically increases daily trading liquidity, and opens the door for mandatory, price-insensitive index buying by mid-cap ETFs. 👉 Increased Holdings (Buy)
2 The Federal Reserve implements a 50 bps emergency rate cut due to economic deterioration
Description: While lower rates theoretically help housing affordability, an emergency cut signals severe labor market deterioration, which is the ultimate kryptonite for a mortgage insurer’s loss ratio and default metrics. 👉 Wait and Monitor (Hold)
Action trigger upon risk realization:
1 Management abruptly suspends the $500 million share repurchase program
Description: This signals extreme internal concern regarding impending catastrophic credit losses or severe regulatory PMIERs deficiencies, destroying the core pillar of the bull thesis. 👉 Reduction in Holdings (Sell)
2 Reinsurance markets seize up, preventing the syndication of new Triangle Re ILNs or XOL treaties
Description: Without CRT execution, Enact is forced to retain 100% of its tail risk, severely compressing its capital efficiency, increasing PMIERs required assets, and trapping cash at the operating entity level. 👉 Reduction in Holdings (Sell)
Customized Strategy Guide by Investment Preference:
Defensive Investors: Target entry strictly at the lower bound of the Buy Zone ($45.00), prioritizing the safety of the 1.93% dividend yield and relying entirely on the company’s buyback program to generate slow, compounding returns without assuming outsized macro housing risk.
Neutral Investors: Enter at the $47.00 midpoint; reinvest all dividends immediately to compound the share reduction effect, and actively monitor monthly GSE delinquency data and national employment reports for any early-warning signs of consumer credit cracking.
Aggressive Investors: Accumulate near current levels and utilize out-of-the-money put options to hedge against sudden, uncoordinated Genworth block liquidations; focus entirely on the massive EPS leverage generated by the shrinking float.
🕵️♂️ Deep Dive Analysis
Q1: Is Enact’s Reliance on the GSEs (Fannie Mae and Freddie Mac) Its Biggest Weakness?
Analysis: Enact operates in an industry completely dominated by a government-sponsored duopoly. Fannie Mae and Freddie Mac dictate the Private Mortgage Insurer Eligibility Requirements (PMIERs), establish the pricing grids (LLPAs) that determine mortgage insurance competitiveness, and ultimately control the pipeline of conventional loans. This creates a severe single-point-of-failure risk. If the Federal Housing Finance Agency (FHFA) decides to alter pricing to favor FHA loans or arbitrarily increases PMIERs capital thresholds—as seen in the recent August 2024 guidance updates affecting NAIC 1 and NAIC 2 bonds—Enact has zero recourse. The entire business model is structurally captive to the political and regulatory whims of Washington, D.C., rendering the company a perpetual price-taker in the broader macroeconomic system.
Judgment:Negative — The extreme concentration of regulatory power within the GSEs represents a perpetual, unmitigable existential threat that permanently caps the valuation multiples the broader market is willing to award Enact, regardless of how flawlessly management executes on capital returns.
Q2: Can Enact’s 10.4x Trailing P/E Be Justified Given the Macroeconomic Housing Affordability Pressures?
Analysis: At first glance, a 10.4x P/E for a company generating a 13.0% ROE appears absurdly cheap. However, the market is intelligently pricing in the reality of peak cycle margins. Record-low delinquencies and massive reserve releases ($37 million in Q2 2026, $60 million in Q4 2025) are artificially inflating current EPS. Simultaneously, 30-year mortgage rates hovering near 6.5% have frozen housing mobility, restricting the total addressable market for new insurance written. The market correctly assesses that Enact is currently over-earning its normalized run-rate. The 10.4x multiple is not a deep value anomaly; it is a rational discounting mechanism applied to a highly cyclical financial entity that is currently coasting on the unrepeatable tailwinds of pandemic-era home price appreciation and pristine borrower credit.
Judgment:Fairly Valued — The multiple perfectly balances the company’s elite current cash generation and buyback velocity against the mathematical certainty that loss ratios will eventually mean-revert higher and reserve releases will dry up.
Q3: How Does Enact’s Credit Risk Transfer (CRT) Program Insulate Its Balance Sheet?
Analysis: Enact has brilliantly transformed its balance sheet from a traditional “buy-and-hold” risk repository into a dynamic “buy-manage-distribute” engine. Through its Triangle Re Insurance-Linked Note (ILN) platform and traditional quota-share and excess-of-loss (XOL) reinsurance treaties, Enact syndicates the catastrophic tail-risk of its mortgage portfolio directly to global capital markets. Since 2015, the company has executed over $4.4 billion in CRT transactions. For example, the $248 million Triangle Re 2023-1 issuance transferred specific mezzanine risk tranches to institutional investors. This strategy is pure financial alchemy: it permanently lowers the required PMIERs capital Enact must hold, vastly improves the company’s return on equity by leveraging third-party capital, and structurally protects the enterprise from a 2008-style housing collapse.
Judgment:Positive — The mastery of the CRT market is Enact’s ultimate defensive weapon, allowing it to free up billions in excess capital to funnel directly into aggressively accretive share repurchases while isolating the balance sheet from catastrophic mortgage default waves.
Q4: Will Genworth’s 81% Majority Ownership Suppress Enact’s Valuation Multiples?
Analysis: Genworth Financial’s absolute dominance of Enact’s cap table—holding 111.6 million shares—is a permanent anchor on the stock. With an 81% stake, Enact is a “controlled company,” meaning minority shareholders are completely disenfranchised. More critically, it strangles trading liquidity and prevents inclusion in major indices that demand higher free-float thresholds. While Genworth currently acts responsibly—selling shares proportionally during Enact’s buybacks to maintain its 81.6% stake—the ever-present risk remains that Genworth, which has its own legacy Long-Term Care (LTC) liabilities, could be forced to dump a massive block of Enact shares to raise emergency cash.
Judgment:Negative — Until Genworth executes a clean spin-off or a managed secondary offering to completely divest its stake, the market will continuously and severely penalize Enact with a “liquidity and control” discount, suppressing any potential multiple expansion.
Q5: How Do the Updated PMIERs Capital Requirements Impact Enact’s Dividend and Buyback Trajectory?
Analysis: In August 2024, the GSEs introduced updated PMIERs standards that excluded certain NAIC 1 and 2 designated bonds from qualifying as available assets. While this mechanically lowered Enact’s theoretical sufficiency ratio from 169% down to 153% at the time, the real-world impact has proven entirely immaterial. The company swiftly repositioned its investment portfolio and still maintains a colossal $1.89 billion buffer (161% sufficiency) above the strict requirements as of Q2 2026. Management has explicitly confirmed that the phased-in PMIERs updates—running through September 2026—will not alter or restrict the planned trajectory of the $500 million share repurchase program or the quarterly dividend.
Judgment:Positive — The seamless navigation of the updated PMIERs framework demonstrates the immense sheer scale of Enact’s excess capital, proving that shareholder returns are safely insulated from routine regulatory tinkering by the FHFA.
Q6: Are Historically High Persistency Rates Sustainable if Mortgage Rates Fall?
Analysis: Enact’s primary persistency rate sits at a highly elevated 80%, largely because borrowers are “locked in” to low-rate mortgages acquired prior to the 2022 rate hikes. This is a massive tailwind, as it keeps highly profitable, seasoned policies on the books generating recurring premium revenue without the acquisition costs of new business. However, this is a dangerous double-edged sword. If the Federal Reserve embarks on a sustained rate-cutting cycle and mortgage rates drop back toward 5.5%, a tidal wave of refinancing will occur. This will trigger immediate cancellations of existing policies, instantly collapsing the persistency rate and rapidly shrinking Enact’s primary insurance-in-force unless new purchase volume can outpace the runoff.
Judgment:Neutral — Elevated persistency is a temporary macroeconomic artifact; while it currently drives immense profitability, investors must mathematically model a severe normalization as soon as the interest rate environment materially softens.
Q7: Does Enact Possess a Tangible Economic Moat Against Rivals Like Radian and Essent?
Analysis: In the private mortgage insurance sector, product differentiation is virtually nonexistent. The GSEs mandate the exact coverage terms, and proprietary black-box pricing engines ensure that rates across Enact, Radian, and Essent remain nearly identical. The true moat is not against existing peers, but against new entrants. The prohibitive billions in PMIERs capital required to start a new PMI, combined with the decades required to integrate into the loan origination software (LOS) of thousands of regional banks, makes the industry an impenetrable fortress. Enact wins not by having a better product than Radian, but by operating in an oligopoly where all players rationally prioritize ROE and capital sufficiency over destructive price wars.
Judgment:Positive — The structural industry moat guarantees that Enact and its five peers will continue to generate utility-like, low-teens returns on equity in perpetuity, sheltered entirely from disruptive startup competition.
Q8: What Impact Will Rising Non-Performing Loan Settlements Have on Enact’s Loss Ratio?
Analysis: The exceptionally low 14% loss ratio enjoyed in Q2 2026 is mathematically unsustainable over a full economic cycle. As the 2023 and 2024 mortgage vintages season and age into their peak historical default years, new delinquencies will mechanically rise. Furthermore, the massive home price appreciation (HPA) that allowed delinquent borrowers to profitably sell their homes and avoid foreclosure (cures) is beginning to plateau in key geographic markets. As the cure rate normalizes from its current 50% high back down to historical averages, the volume of paid claims will inevitably rise, driving the loss ratio back toward the 25-30% historical range.
Judgment:Negative — The normalization of the loss ratio is an unavoidable mathematical certainty; future earnings growth will face severe headwinds as the massive subsidy of prior-year reserve releases inevitably evaporates.
Q9: Can Enact Sustain Its 13% Return on Equity in a Stagnant Origination Market?
Analysis: Top-line growth is paralyzed by the frozen housing market, but Enact’s 13.0% ROE is completely independent of revenue growth. The secret is the denominator. By generating nearly $700 million in annual net income and aggressively funneling it into the $500 million share repurchase program, Enact is systematically destroying its own equity base at a massive discount to intrinsic value. This financial engineering ensures that even if total net income stays flat or declines slightly due to normalizing loss ratios, the earnings per share (EPS) and the return on the remaining equity will continue to compound reliably.
Judgment:Positive — The ruthless efficiency of the capital return program mathematically guarantees the preservation of a low-teens ROE, effectively decoupling the company’s per-share profitability from the stagnation of the macro housing cycle.
Q10: Is the Rapid Expansion of the Triangle Re ILN Platform Introducing Unforeseen Systemic Risks?
Analysis: The Triangle Re platform relies entirely on syndicating risk to yield-hungry institutional investors in the capital markets via Insurance-Linked Notes (ILNs), such as the $248 million Triangle Re 2023-1. While this brilliant strategy currently provides Enact with massive capital relief, it introduces a dangerous reliance on secondary market liquidity. If a broader macroeconomic crisis triggers a sudden risk-off environment across the shadow banking sector, credit spreads on these ILNs will blow out. If the capital markets suddenly refuse to digest new Triangle Re issuances, Enact would be forced to retain 100% of its newly originated tail risk, causing its PMIERs required assets to skyrocket precisely when capital is most scarce.
Judgment:Neutral — While CRT execution is currently a massive strength, it inherently tethers Enact’s balance sheet flexibility to the whims and stability of global shadow-banking liquidity, creating a latent vulnerability during severe systemic liquidity shocks.